"AromeManpo Fragrance Full House" Completes Nearly 100-Million-Yuan B-Round Financing, to Exceed 10 Offline Stores This Year.
Nearly 100 million yuan in Series B funding for 15% equity—this transaction is less a financial investment by Yingtong Holdings in a rising beauty brand, and more a cautious probe by a traditional giant into a "new narrative." In a climate of普遍 capital restraint, Fuyu Manpu's ability to secure funding itself demonstrates its narrative strength. However, stripping away the glamorous packaging of concepts like "Eastern Aromatherapy" and "Emotional Skincare," is the core built on solid skincare sci
Analysis
Nearly 100 million yuan in Series B funding for 15% equity—this transaction is less a financial investment by Yingtong Holdings in a rising beauty brand, and more a cautious probe by a traditional giant into a "new narrative." In a climate of generally restrained capital, Fuyu Manpu's ability to secure funding itself demonstrates its narrative strength. However, stripping away the glamorous packaging of concepts like "Eastern Aromatherapy" and "Emotional Skincare," is the core built on solid skincare science, or meticulously packaged sensory marketing? That is the crucial question.
The brand's story is comprehensively told: founder Jiang Teng boasts "decades of aromatherapy heritage," the brand synthesizes "plant wisdom from both East and West," it has even established a research center with Jiangnan University and holds two patents for tuberose raw materials. This comprehensive approach—spanning history, technology, and industry-academia collaboration—precisely targets modern consumers' dual thirst for "cultural confidence" and "ingredient narratives." From fermented tuberose liquid to black iris root stem cells, the raw material storytelling brims with a blend of Eastern mysticism and modern biotech allure. But viewed calmly, these stories all lead to one end: premium pricing. Whether it's tuberose's "pioneering efficacy aromatherapy" or black iris's "high-end anti-aging repair," they essentially provide theoretical justification for products to escape the mass-market price band.
What truly offers investors and outsiders room for imagination might be its channel ambitions. Post-funding, the company explicitly plans to use proceeds for offline store expansion, aiming to exceed 20 stores by 2027. Flagship stores of 300-500 square meters will create an "immersive Eastern aromatherapy five-sense healing space" infused with herbal tea offerings. This sounds less like a skincare store and more like a cultural experience hall or high-end lifestyle collection store. Partner Yingtong Holdings, as a traditional perfume retail giant, holds value in helping Fuyu Manpu quickly access premium offline channels. However, this asset-heavy, experience-driven model is no less than a gamble amid today's challenges with offline traffic and consumer willingness. It bets that those willing to pay for a custom brew or afternoon tea ambiance will eventually pay a steep premium for the essence oil inside the bottle.
The brand claims to "scientifically verify" emotional skincare efficacy by monitoring users' brainwaves and cortisol levels, aiming to fill an industry gap. This sounds cutting-edge but also resembles a "scientific showcase" geared towards investors and media. For ordinary consumers, do they truly care about their cortisol levels? Or are they more concerned with immediate skin feel and long-term visible changes upon application? "Emotion" is an extremely subjective and marketing-driven concept; forcibly tying it to rigorous "efficacy validation" may ultimately amount to a hollow platitude.
The target of 600 million yuan in omnichannel GMV by 2025 is quite aggressive. Supporting this figure, besides the existing tuberose series, is the just-launched black iris high-end line. But building user loyalty, managing repurchase cycles, and educating the market for premium skincare are not overnight achievements. While the brand views the black iris line as a "second growth curve," is the first "tuberose curve" itself sufficiently solid? The fact that star products contribute most of the sales revenue actually underscores the brand's current deep reliance on a single product line, raising doubts about its risk resilience.
As for overseas expansion, the brand plans to start with Hong Kong and Macau, then move into Japan, South Korea, and Southeast Asia, emphasizing the creation of "high-end independent experience stores." This sounds ambitious, but the reality is that Chinese brands have gradually gained insights in overseas supply chains and online channels, whereas expanding high-end offline experience stores abroad faces multiple formidable barriers: brand recognition, localized operations, and cultural divides. Relying on Yingtong's channel enablement is merely the first step. The real challenge lies in whether overseas markets resonate with your "Eastern aromatherapy story," and whether you have the patience and capital to slowly cultivate premium brand recognition from scratch.
Fuyu Manpu indeed paints an alluring picture: capital backing, scientific endorsement, channel support, and cultural empowerment. It precisely rides the wave of domestic product premiumization and consumption segmentation. Yet, all grand blueprints must ultimately pass two tests: consumers' wallets and the judgment of time. Once the conceptual narrative concludes, can the product deliver irreplaceable value? When novelty fades, will the "healing space" experience still draw repeat visits? Nearly 100 million yuan is ammunition, but the target to capture is the fortress of "true premium" perception in consumers' minds. This path is destined to be long and costly.
Disclaimer: The above content is generated by AI and is for reference only.